Appetite support
Semaglutide and tirzepatide affect pathways involved in appetite and calorie intake.
← All treatments
Medical weight management
GLP-1 Weight Management
Semaglutide and tirzepatide work with appetite-regulating pathways. For eligible adults, treatment may support weight reduction and long-term weight management alongside nutrition and physical activity.
Individual results vary. A medical consultation is required to determine whether treatment may be appropriate for you.
Ask about weight management
What it does
It works with the signals involved in appetite and food intake.
GLP-1 is a hormone involved in appetite and calorie intake. Semaglutide acts at the GLP-1 receptor. Tirzepatide acts at both the GIP and GLP-1 receptors.
By affecting appetite and calorie intake, these medications can support weight reduction when used as part of an ongoing plan. They do not replace nutrition, physical activity, or medical follow-through.
Potential benefits
Support for appetite, weight reduction, and long-term management.
Weight reduction
For eligible adults, treatment may support meaningful weight reduction when paired with nutrition and physical activity.
Long-term management
GLP-1 medication is used as ongoing medical care to support weight reduction and maintenance, not as a one-time treatment.
Benefits and side effects vary from person to person. No specific amount or pace of weight change can be promised.
Semaglutide
Acts at the GLP-1 receptor.
Semaglutide is a GLP-1 receptor agonist. Its effects on appetite and calorie intake are part of how it supports weight management.
Tirzepatide
Acts at both GIP and GLP-1 receptors.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. The receptor difference does not determine which medication is right for a particular person.
Medical oversight
What the program consists of.
Diana Morrison, RN provides GLP-1 weight management under written physician protocol and medical direction. The consultation is where your goals and the appropriateness of treatment are considered before a medication decision is made.
Medical Director: Joshua Shaw, MD · FL Lic. ME136232
Prepare and follow through
Download the treatment care guides.
Use the GLP-1 Weight Management section in each guide. Instructions provided for your medication and individual plan always take priority.
Common questions
GLP-1 weight management: frequently asked questions
What does GLP-1 mean? +
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite and calorie intake. Semaglutide acts at the GLP-1 receptor. Tirzepatide acts at both the GIP and GLP-1 receptors.
What can GLP-1 weight management help with? +
For eligible adults, semaglutide or tirzepatide may support weight reduction and long-term weight management by affecting appetite and calorie intake. Individual response varies, and medication works alongside nutrition and physical activity rather than replacing them.
Are semaglutide and tirzepatide the same medication? +
No. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts at both the GIP and GLP-1 receptors. A medical consultation determines whether either option may be appropriate for an individual client.
Who provides GLP-1 weight management at House of Rose? +
Diana Morrison, RN provides the service under written physician protocol and medical direction. Medical Director: Joshua Shaw, MD · FL Lic. ME136232.
How do I know whether I may be a candidate? +
GLP-1 medications are not appropriate for everyone. A medical consultation is needed to review whether this type of treatment fits your health history, current medications, and weight-management goals.
Ask whether GLP-1 weight management fits your goals.
Contact House of Rose to begin a conversation about the program and your next step.
Contact House of RoseClinical information reviewed against current U.S. Food and Drug Administration prescribing information.